Department of Health – Abu Dhabi and AstraZeneca Expand Partnership During BIO 2024 to Establish New Rare Diseases Centre of Excellence

ABU DHABI, UAE, June 5, 2024 /PRNewswire/ — The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with AstraZeneca during BIO International Convention 2024 to establish a world-class Rare Diseases Centre of Excellence (CoE) in Abu Dhabi. Leveraging Abu Dhabi’s advanced healthcare infrastructure and AstraZeneca’s global expertise and experience in rare diseases management, the two entities will spearhead innovation to improve the lives of people and communities impacted by rare diseases, regionally and globally.

In the presence of H.E. Mansoor Ibrahim Al Mansoori, Chairman of DoH and Hicham Mirghani, GCC and Pakistan Corporate Affairs Director …

Full story available on Benzinga.com